A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study

INTRODUCTION: This phase 2b/3 trial examined the effects of plasma exchange (PE) in patients with mild‐to‐moderate Alzheimer's disease (AD). METHODS: Three hundred forty‐seven patients (496 screened) were randomized (1:1:1:1) into three PE treatment arms with different doses of albumin and intr...

Descripción completa

Detalles Bibliográficos
Autores principales: Boada, Mercè, López, Oscar L., Olazarán, Javier, Núñez, Laura, Pfeffer, Michael, Paricio, María, Lorites, Jesús, Piñol‐Ripoll, Gerard, Gámez, José E., Anaya, Fernando, Kiprov, Dobri, Lima, José, Grifols, Carlota, Torres, Mireia, Costa, Montserrat, Bozzo, Jordi, Szczepiorkowski, Zbigniew M., Hendrix, Suzanne, Páez, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Featured Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984263/
https://www.ncbi.nlm.nih.gov/pubmed/32715623
http://dx.doi.org/10.1002/alz.12137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984263/
https://www.ncbi.nlm.nih.gov/pubmed/32715623
http://dx.doi.org/10.1002/alz.12137

Ejemplares similares